Is FDG-PET indicated for superficial esophageal cancer?☆ | Zendy

Sherard G. Little | Zendy; Thomas W. Rice | Zendy; Bohdan Bybel | Zendy; David P. Mason | Zendy; Sudish C. Murthy | Zendy; Gary W. Falk | Zendy; Lisa Rybicki | Zendy; Eugene H. Blackstone | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is FDG-PET indicated for superficial esophageal cancer?☆

Author(s) -

Sherard G. Little,

Thomas W. Rice,

Bohdan Bybel,

David P. Mason,

Sudish C. Murthy,

Gary W. Falk,

Lisa Rybicki,

Eugene H. Blackstone

Publication year - 2007

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1016/j.ejcts.2007.01.037

Subject(s) - positron emission tomography , medicine , submucosa , standardized uptake value , esophageal cancer , fluorodeoxyglucose , nuclear medicine , cancer , esophagus , colorectal cancer , radiology , pathology

To ascertain whether fluorodeoxyglucose positron emission tomography is indicated for clinical staging of superficial cancer, we sought to determine if it accurately classifies tumor (T), regional nodal (N), and distant metastases (M), including distinguishing high-grade dysplasia (Tis) from invasive cancer (T1).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research